Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of SR121463B in correcting hyponatremia in patients with syndrome of
inappropriate antidiuretic secretion (SIADH).To assess the long-term efficacy of SR121463B in
maintaining normal levels of serum sodium in patients with SIADH. To assess the safety and
tolerability of SR121463B in patients with SIADH.
The double blind period is followed by an open label extension study with flexible doses of
satavaptan.